KATHLEEN JOSLIN: Open Payments
NPI 1306198064 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 26 payments from 11 companies in 2025. Trend: 2023 $25 · 2024 $0 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $94 |
| Lilly USA, LLC | 5 | $87 |
| PFIZER INC. | 4 | $71 |
| Exact Sciences Corporation | 2 | $44 |
| Esperion Therapeutics, Inc. | 3 | $43 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Astellas Pharma US Inc | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Dexcom, Inc. | 1 | $20 |
| Almatica Pharma LLC | 1 | $17 |
Products named: EVENITY, MOUNJARO, Cologuard Collection Kit, NEXLETOL, FARXIGA, Veozah, NURTEC ODT, LEQVIO.
Industry payments across GA — which companies pay providers there.
